JP2019506397A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506397A5
JP2019506397A5 JP2018538168A JP2018538168A JP2019506397A5 JP 2019506397 A5 JP2019506397 A5 JP 2019506397A5 JP 2018538168 A JP2018538168 A JP 2018538168A JP 2018538168 A JP2018538168 A JP 2018538168A JP 2019506397 A5 JP2019506397 A5 JP 2019506397A5
Authority
JP
Japan
Prior art keywords
capsaicin
dose
metatarsal
formulation
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018538168A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506397A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/014257 external-priority patent/WO2017127628A1/en
Publication of JP2019506397A publication Critical patent/JP2019506397A/ja
Publication of JP2019506397A5 publication Critical patent/JP2019506397A5/ja
Pending legal-status Critical Current

Links

JP2018538168A 2016-01-22 2017-01-20 モートン神経腫疼痛の治療のためのカプサイシン連続投薬方法 Pending JP2019506397A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662281877P 2016-01-22 2016-01-22
US62/281,877 2016-01-22
PCT/US2017/014257 WO2017127628A1 (en) 2016-01-22 2017-01-20 Capsaicn sequential dosing method for treatment of morton's neuroma pain

Publications (2)

Publication Number Publication Date
JP2019506397A JP2019506397A (ja) 2019-03-07
JP2019506397A5 true JP2019506397A5 (https=) 2020-02-27

Family

ID=59362242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018538168A Pending JP2019506397A (ja) 2016-01-22 2017-01-20 モートン神経腫疼痛の治療のためのカプサイシン連続投薬方法

Country Status (7)

Country Link
US (2) US20190022036A1 (https=)
EP (1) EP3405187A4 (https=)
JP (1) JP2019506397A (https=)
CN (1) CN108697673A (https=)
AU (1) AU2017210315A1 (https=)
CA (1) CA3011647A1 (https=)
WO (1) WO2017127628A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102657458B1 (ko) 2016-11-02 2024-04-12 센트렉시온 테라퓨틱스 코포레이션 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도
WO2019018769A1 (en) 2017-07-20 2019-01-24 Centrexion Therapeutics Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE
EP3840739B1 (en) * 2018-08-24 2025-11-12 Centrexion Therapeutics Corporation Capsaicin sequential dosing method for treatment of knee joint pain
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156931A1 (en) * 2002-12-18 2004-08-12 Algorx Administration of capsaicinoids
PT1605956E (pt) * 2002-12-18 2016-03-09 Centrexion Therapeutics Corp Administração de capsaicinóides para o tratamento da osteoartrite
EP3388057B1 (en) * 2011-09-09 2022-03-09 Propella Therapeutics, Inc. A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof
AU2013341380B2 (en) * 2012-11-12 2018-04-26 Propella Therapeutics, Inc. Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid

Similar Documents

Publication Publication Date Title
Biboulet et al. Postoperative analgesia after total-hip arthroplasty: comparison of intravenous patient-controlled analgesia with morphine and single injection of femoral nerve or psoas compartment block. A prospective, randomized, double-blind study
KR101900520B1 (ko) 복합 조성물
JP2019506397A5 (https=)
EA006384B1 (ru) Композиция фентанила для интраназального введения
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
EP0123469B1 (en) Use of fluoxetine for the manufacture of an anti-anxiety agent
JP6196704B2 (ja) 神経因性疾病の治療のための医薬
CA2735834C (en) Composition comprising ibuprofen and paracetamol to treat pain caused by osteoarthritis and rheumatoid arthritis
Goold Postoperative spasticity and shivering: a review with personal observations of 500 patients
ES2210025T3 (es) Agente farmaceutico para el tratamiento de estados convulsivos.
Radbruch et al. High-dose oral morphine in cancer pain management: a report of twelve cases
KR102927058B1 (ko) 진통 가려움 완화 약학 조성물 및 그 응용 방법
JPH061721A (ja) 疼痛処置剤、及び疼痛軽減作用増強剤
KR102829253B1 (ko) 지방분해용 주사제 조성물
CN111821423A (zh) 一种白介素2用于治疗慢性自发性荨麻疹的应用
AU2009274022B2 (en) Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis
US20040006052A1 (en) Injection solutions to treat neuropathic symptoms and other sensorimotor disorders that are due to neuromas of the foot or other entrapment neuropathies of peripheral nerves, and method of use
S Mohamed et al. Ultrasound-Guided Lumbar Erector Spinae Plane Block compared to Quadratus Lumborum Block for Postoperative Analgesia in Inguinal Hernia repair operations
Tekol et al. Ephedrine diminishes some side effects of morphine
RU2020111649A (ru) Лечение патологических состояний кости у пациентов с дефицитом кислой сфингомиелиназы
US20110245212A1 (en) Methods of alleviating the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
Solca et al. 10 Comparison of hyperbaric lidocaine and mepivacainein outpatient saphena stripping
Mermelstein Safety and efficacy of intranasal ketamine for acute postoperative pain
JPWO2020041658A5 (https=)
JP2004168762A (ja) 点鼻剤組成物